Abstract #3159

Brain volume measurements in multiple sclerosis patients: a novel combination approach for routine clinical assessment in MS PATHS

Adrian Tsang¹, Yu-Chen Su¹, Rodrigo D Perea¹, Ricardo Corredor-Jerez^2,3,4, Mário João Fartaria^2,3,4, Till Huelnhagen^2,3,4, Veronica Ravano⁴, Bénédicte Maréchal^2,3,4, Tobias Kober^2,3,4, Robert A Bermel⁵, Stephen E Jones⁵, Izlem Izbudak⁶, Yvonne W Lui⁷, Lauren Krupp⁷, Ellen M Mowry⁶, James R Williams¹, Rick Rudick¹, and Elizabeth Fisher¹

¹Biogen, Cambridge, MA, United States, ²LTS5, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, ³Department of Radiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, ⁴Advanced Clinical Imaging Technology, Siemens Healthcare AG, Lausanne, Switzerland, ⁵Cleveland Clinic, Cleveland, OH, United States, ⁶Johns Hopkins University, Baltimore, MD, United States, ⁷New York University, New York, NY, United States

Highly precise measurements from fully automated techniques are required to quantify brain atrophy in individual multiple sclerosis (MS) patients. We developed a novel approach to reliably estimate brain atrophy in MS that combines two techniques applied to different image contrasts and incorporates inter-scanner calibrations. We validated this approach using data acquired in a scan-rescan study. Mean coefficient of variation (CV) for the new brain parenchymal fraction measurement was 0.18%, which was lower than the CV attained for the individual techniques. This new metric will next be integrated into the radiology workflow in MS PATHS institutions for further testing.

This abstract and the presentation materials are available to members only; a login is required.

Join Here